Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P52
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.82% |
| Q3 2025 | -10.31% |
| Q2 2025 | 2.88% |
| Q1 2025 | -5.01% |
| Q4 2024 | 22.67% |
| Q3 2024 | -147.87% |
| Q2 2024 | 275.95% |
| Q1 2024 | -6.58% |
| Q4 2023 | -2.01% |
| Q3 2023 | -0.54% |
| Q2 2023 | 2.32% |
| Q1 2023 | 0.12% |
| Q4 2022 | -14.86% |
| Q3 2022 | 28.86% |
| Q2 2022 | -31.68% |
| Q1 2022 | -10.35% |
| Q4 2021 | -13.43% |
| Q3 2021 | -5.53% |
| Q2 2021 | -15.48% |
| Q1 2021 | 4.18% |
| Q4 2020 | 6.89% |
| Q3 2020 | -19.97% |
| Q2 2020 | 15.28% |
| Q1 2020 | -13.98% |
| Q4 2019 | 3.03% |
| Q3 2019 | -26.03% |
| Q2 2019 | 63.75% |
| Q1 2019 | -302.41% |
| Q4 2018 | -1.79% |
| Q3 2018 | -15.79% |
| Q2 2018 | -7.37% |
| Q1 2018 | 0.00% |